Advertisement

Topics

Pamplona Capital Management nears deal to buy Parexel - WSJ

08:48 EDT 20 Jun 2017 | Topix

Private equity firm Pamplona Capital Management is nearing a deal to buy contract drug research firm Parexel International Corp for $4.6 billion, the Wall Street Journal reported on Tuesday. Pamplona is set to pay $88.10 a share in cash as part of the deal, the newspaper said citing people familiar with the matter.

Original Article: Pamplona Capital Management nears deal to buy Parexel - WSJ

NEXT ARTICLE

More From BioPortfolio on "Pamplona Capital Management nears deal to buy Parexel - WSJ"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...